| Date | Time | Source | |
| 06/13/2013 | 6:20PM | DJN | UPDATE: Lilly Ends Alzheimer's Drug Study On Safety Concern
--Lilly stops study of Alzheimer's drug, cites abnormal liver tests in some patients --Lilly doesn't believe liver tests are related to drug's mechanism of action --Latest in series of research setbacks in industry's hunt for better Alzheimer's treatment (Adds details and background throughout.) By Peter Loftus Eli Lilly... More...>> |
| 06/12/2013 | 5:02AM | ZACKS | Bear of the Day: Covidien (COV) - Bear of the Day
In the wake of its dismal fiscal 2013 second quarter results, analysts covering Covidien PLC (COV), the $30 billion medical products maker, slashed earnings estimates for both this year and next by 17% each. Not only did net income decline by 10.2% due to higher expenses, the company also warned about future investment-related... More...>> |
| 05/23/2013 | 9:00AM | BW | Baxter to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11, 2013 at 4:40 p.m. (CT). The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for... More...>> |
| 05/21/2013 | 9:00AM | BW | Baxter Receives Marketing Authorization for HyQvia in European Union
Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced that the European Commission has granted Baxter marketing authorization in all European Union (EU) Member States for the use of HyQvia (solution for subcutaneous use) as replacement therapy for adult patients with primary... More...>> |
| 05/20/2013 | 9:00AM | BW | Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013 at 7:00 a.m. (CT). The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available... More...>> |
| 05/17/2013 | 6:40AM | ZACKS | Tiffany Hikes Dividend - Analyst Blog
Tiffany & Company (TIF), a high-end jewelry designer, manufacturer and retailer, revealed its plan to utilize its free cash to boost stakeholders’ return by announcing a dividend hike. The N.Y. based company, raised its quarterly dividend by 6% to 34 cents (or $1.36 annually) from 32 cents a share (or $1.28 annually... More...>> |
| 05/17/2013 | 6:40AM | ZACKS | Tiffany Hikes Dividend - Analyst Blog
Tiffany & Company (TIF), a high-end jewelry designer, manufacturer and retailer, revealed its plan to utilize its free cash to boost stakeholders’ return by announcing a dividend hike. The N.Y. based company, raised its quarterly dividend by 6% to 34 cents (or $1.36 annually) from 32 cents a share (or $1.28 annually... More...>> |
| 05/15/2013 | 10:20AM | ZACKS | Fresenius Teams with ApolloMed - Analyst Blog
Dialysis company Fresenius Medical Care (FMS) and Apollo Medical Holdings, Inc. (ApolloMed, AMEH) revealed an agreement under which ApolloMed subsidiary ApolloMed ACO is joining hands with Fresenius Medical Care. Their purpose will be to provide composite treatment for ApolloMed patients suffering from end stage renal... More...>> |
| 05/09/2013 | 9:00AM | BW | Health Statistics Pioneer Dorothy P. Rice, Sc.D., Named 2013 Recipient of the William B. Graham Prize for Health Services Res...
Dorothy P. Rice, Sc.D., has been named the 2013 recipient of the William B. Graham Prize for Health Services Research. The Prize, funded by The Baxter International Foundation and managed by the Association of University Programs in Health Administration (AUPHA), will be awarded on June 20, 2013 during the AUPHA Annual... More...>> |
| 05/07/2013 | 8:34AM | DJN | Baxter's Potential Alzheimer's Treatment Immunoglobulin Misses Primary Endpoints
By Saabira Chaudhuri Baxter International Inc. (BAX) said results from a late-stage study of its potential treatment for Alzheimer's, immunoglobulin, were negative. The results didn't meet the co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's... More...>> |
| 05/07/2013 | 7:15AM | BW | Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Baxter International Inc. (NYSE:BAX) today announced that its Phase III clinical study of immunoglobulin (IG) did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer’s disease. The Gammaglobulin Alzheimer’s Partnership (GAP... More...>> |
| 05/06/2013 | 5:00PM | BW | Baxter Raises Dividend Nine Percent
Baxter International Inc. (NYSE:BAX) today announced it is increasing its dividend for shareholders by nine percent. Baxter’s Board of Directors declared a quarterly dividend of $0.49 per Baxter common share, payable on July 1, 2013 to shareholders of record as of the close of business on June 7, 2013. This maintains... More...>> |
| 05/06/2013 | 6:30AM | GLOBE | Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
SAN DIEGO, May 6, 2013 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the online publication1 of Baxter's (Baxter International Inc.) (NYSE:BAX) preclinical evaluations of Vical's Vaxfectin® adjuvant in combination with Baxter's cell culture-derived seasonal and pandemic influenza vaccines. Simple... More...>> |
| 05/01/2013 | 4:58AM | ZACKS | Fresenius Earnings Lower Y/Y - Analyst Blog
Dialysis company Fresenius Medical Care (FMS) announced first quarter 2013 earnings per ordinary share of 74 cents which was 8% lower than the year-ago adjusted earnings per share of 80 cents. Net income attributable to the company dropped 39% year over year to $225 million (or 74 cents per share) in the quarter. Quarter... More...>> |
| 04/25/2013 | 4:15PM | BW | Baxter to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Tuesday, May 14, 2013 at 5:40 p.m. (CT). The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for... More...>> |
| 04/24/2013 | 4:15PM | BW | Baxter to Webcast Annual Meeting of Shareholders
Baxter International Inc. (NYSE: BAX) will webcast its annual meeting of shareholders on Tuesday, May 7, 2013, at 9:00 a.m. Central Time. This meeting is being webcast by Thomson Reuters and can be accessed along with accompanying slides from Baxter’s Web site at www.baxter.com. The meeting will be recorded by Baxter... More...>> |
| 04/24/2013 | 9:00AM | BW | Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research
Baxter International Inc. (NYSE:BAX) today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research in Baltimore, Md. In this Phase I/II study, the candidate... More...>> |
| 04/23/2013 | 10:50AM | ZACKS | Reiterate Baxter at Neutral - Analyst Blog
On Apr 22, we reiterated Baxter International (BAX) at Neutral, based on the company’s narrow beat of the Zacks Consensus Estimate for earnings. We also noted the company’s maintenance of earlier issued guidance for 2013. Why the Reiteration? Baxter reported first quarter adjusted (excluding one-time items... More...>> |
| 04/23/2013 | 10:01AM | DJN | Health-Care Companies Report Slowdown in Patient Visits
By Peter Loftus and Joseph Walker The spike late last year in doctor and hospital visits apparently lasted as long as the flu. After years of decelerating health-care usage--linked to economic problems in the U.S. and Europe--the recent uptick increased optimism that a corner was being turned. The upswing was tied to more... More...>> |
| 04/19/2013 | 5:36AM | ZACKS | Company News for April 19, 2013 - Corporate Summary
• American Express Company (NYSE:AXP) reported first quarter earnings per share of $1.15, beating the Zacks Consensus Estimate of $1.11 • Verizon Communications Inc. (NYSE:VZ) posted first quarter earnings per share of $0.68, ahead of the Zacks Consensus Estimate of $0.66 • ... More...>> |
